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INTRODUCTION 
The possibility of dest:~?oying or weakening cancer 
cells by the general or selective absorption of neutrons 
l;>y cells was first pointed qut by Locher in 1939 (1). 
Boron or lithium atoms were suggested as the absorbing 
~----=a,gent sino e . they_w_e_gpo_d __ a.c_o_ept_o:ros_of:_ne_utron$ ~-N eutt>o:n ____ -~-~- _ 
capture by ei·cher boron or lithium atoms pt>oduoes high 
energy alpha radiation. The radiation· is localized and 
confined to the a:~ea: of bti:t"ort or lithium concentration 
because the mean f'ree path of the alpha particl(\ls produced 
is approximately equal to the diameter of-a single oell. 
The nuclear reactions for boron and lithium are 
as follows: 
For lithiuxn: 
Locher also pointed out that neutrons themselves 
, ... ,_" < .,·.~ 
cause very little darnae;e to tissue, and th:us they are an 
improve~ent over X:•ray therapy in the treatment of_tumors• 
He emphasized that X .. rays cause equal damage to both 
' ' ~ 
healthy and cancerous tissue. Thus the upper limit of 
2 
the x-ray treatment j.a directly dependant upon the skin. 
damage done. 
In 1940 the first successful use of bor·on as a 
chemotherapeutic agent was reported by Iwuge:r> (2)ii He 
)?epo:rted that neoplastic cells .can be destroyed i,q, v~VSl 
<f·· 
if sufficient boron in some. sui table form. can be applied 
to the tumor !D; vivo.. Zahl• Coopel? and Dunning (3)'. in 
1940 a~so reported significant :tncrease. in tumor reg,ression 
following neutron-beam eXposure of transplantable mouse 
. . ':, . . . ' 
~nwoo:mas injected with boron and lithium oompoUil.diH These 
workers po,.n~ed. out e_t that time that in o:rde:t'> to be 
effective the boron or 11tb.i1lm m.ust be loc~lbted in the 
tumor only and that the swrounding normal .tissue must be 
:Cree of' the materials which would absorb neutronso:: At 
that time such a localization was improbable., 
Localization of suitable neutron absorbers in 
<Hmcerous tissue tve.s begun as early as ·1929 when Ludfox>d 
(4) ;. DWM•Reynals (5) and others reported that certain 
dyes,. when injected :I.nt;ravenously; would concentrate to 
a greater degree in tum~~ tissu<t~ than in normal tissue •. 
In 1941; Zahl and Cooper- (6,7) substituted 'lithium for 
sodium in various azo dyes (e•·g~r ponta:mi.ne sky blue, 
trypan blue,. c ar:minic acid) and administered these 
compounds. intravenously both into· mice having spontaneous· 
mammary .tumors and mice bearing implanted tumors of 
sarcoma l80.t· Deposition. of ·twice as much lithium ln t;he 
l 
tumor as compared to the normal surrounding tissue resulted~· 
Extensive, neutron•beam therapy with cancer patients 
was cal.'t:ried out in 1948 by Stone ('a),' who. published data 
on neutron therapy with two hundred and fifty patients •' 
!n his studies he found that the survival :t?ate of patients 
treated with fast neutrons was very discouraging., stone 
pointed out that slow or thermal neutrons would be the 
--- ----- - -----
only probable neutron thet>apy which could be applied to 
humans. By use of boron•lO,whioh has a greater capture 
potential tor slow neutrons, the effec~s of fast neutrons 
can be overcome. 
Javids sweet and co•tvorlters (9 ,lo) in 1952 reported 
that boron, adrain:tstll)toed intl?a.venously as borax solution, 
concentrated in many :r•apidly growing brain tumors to more 
than three times the extent that it does in normal brain 
tissue. subseqent studies (11) of the concentration 
ratios between neoplasms and surrounding normal tissue 
indicated, however~ that boron•neutron therapy offered 
little promise for treatment of malignant turaors othel" than 
those o:t the brain. 
The use of the neutron-boron•lO reaction in the 
treatment of cancer was studied in 1954 by F•a:r:r • et aJ. 
(12 h They made their studies on ten patients with brain 
tumors (glioblastoma); some of whom received a total ot 
four irradiation treatments given at five to six weeks 
intervals• Depressed tumor growth was noted following 
4 
eight out of twehty one ~!ture the~apy trials • question• 
able improvem~nt being noted in six of the remaining 
thirteen tr-ial~ •.. and no discernible change following 
seven of the treatments. Only one out of five patients 
· hav:f:ng multiple treatments demonstrated no improvement . ,. 
at any time. 
The search for a molecule which tvas preferentially 
absol~bed by cancer•ous ·bissue and to which boron could. be 
attached was implemented in, 1957 vthen Rall, et al (13} 
:beported the appearance and persistence of fluorescent. 
material in tumo:r tissue following administration of the 
tetracycline compounds~ Since the tetracycline con~ounds 
were round to be present in tumor tissue for as long as 
twenty one days following injection it was apparent that 
tetracycline had the potential of acting as the vehicle 
which would earry bo~on•lO to the cancerous tissue~ Of 
' ' 
even greater importance than this discovery was the fact 
that tetracycline could not be detected in normal tissue 
f'orty eight hours afte:~:J the tetracycline administration• 
The absorption of tetracycline has been noted in,oarcinomas, 
sa!'oonu:ts, and some lymphomas, but 1 t is apparently not 
absorbed by melanomas .. 
The objeotiveof' this study is the preparation 
of a te~!"aoycline•boron-.10 derivative which is stable 
under biological conditions. The bor-on ... lO should then 
provide a concentration of material capable of accepting 
1 
I 
I 
thermal neutrons, thus producing localized higkl.•energy 
alpha radiation. The ff16t that the tetracyclines are not 
. ~etained. by norrrial 'Cis sue should :remove· the danger of 
destruction of thi$ ti.ssue. 
. OHAP'l'E:H · II 
.EXPERIMENTAL 
MatElllic lithium will replace aromatic_ halogens 
. . 
under proper conditions (14).· 
7""chlorotetraoycline was selected as the moat suitable 
starting :material for the preparation of a boron-tetra-
cycline compound through the aryl lithium intermediatae 
c 1-13 cl-13 
' / N 
OH 
(1s) + 7 L.A. ) L~C1 c~o 
"NH OH 0 " 
CH3 CJ-1.3 
'N' 
OL..i 
+2:~H~ + c?o 
,, 
"NH 
Ol.A. Ol...A. 0 2.. 
7 ® Aureomyo:ln neutral base, rather than Aureomycin 
hydrochloride, was selected as the starting .material 
because of the reactivity of the chlor-ide ion with lithiume 
Solubilty studies of 7•chlorotetracyolina showed 
maximum solubilities .ot .15 mg/.ml, or less, in benzene, 
nitrobenzene, ethyl acetate, toluene, chloroform, cyclo• 
hexane and d.iathyl ether at 25°0 and 14.9 mg/ml in tetra• 
hydroturan and dioxane at 259 C. Reddish gum•like 
materials, indicating ohem:lcal change, were obtained on 
evaporation of the dioxane solution; thus tetrahydrofurari 
was chosen as the most promising solvent for the study of 
the replacemen·t of the he.logen by lithium. 
The :t'1rst step in the synthesis of tetracycline .. 
7•boronic acid was the preparation of 7·1i thium tetra• 
cyoline. '7·45 grams o.t' Aweo:myc:tn, Neutral, 4ll5Bl6•1, 
lot number 7•910.5. suppl.ied by tederle Laboratories 
Division, American Cynamid o'ompany, was di:·saolved in five 
hundred millili tarsi of' anhydrous ·hetrahydrofl.Wan and 
passed ovet> pea sh~ed pieces or metallic lithium in a 
' 
glass reaction vessel thirty centimeters by one centimeter. 
The lithium metal was held in place by a constriction at 
the lower end of ·the tuba and a cotton plug at the upper 
end of the column containing the metallic li"l;hium• 
Oaloium chloride tubes were built into the apparatus to 
prevent atmospheric moisture hydroly~ing the 7•lithium 
tetracycline •. The solution was passed through the lithium 
8 
column by g:ravtty flow.· Adjustment of the rate of f'lo't.Y 
of the solution wa.s made by a stopcock and adjusted to 
five hundred milliliters o:f'. solution per hotW. A sintered 
glass filter was in~talled below .the reaction vessel to 
remove insoluble materials; chiefly 1ithil.lrt1 chloride, 
formed·dl,.'Wing the reaction. A diagram of' the apparatus 
used appears in figure 1. 
One hundred milliliters of an anhydrous saturated 
solution of boric acid in tetrahydx•ofuran (12.3 :mg/ml) 
-was placed in a one l:tte:r rouhd botto1n flask fitted with 
a refluxcondense:r> and protected from moisture by a 
calcium. chloride tube. The tetrahyd:roturan solution of 
7•lithium tetracycline was added and the resulting 
solution .refluxed for· trwee hours •. 
OL.t. 
oL..t. 
II Qli. 0 
el-l~ ;-cH~. Ho oH 
'8" c.f-1:~. OLA. N 
OLi .. 
I 
OL~ 
Oli. 
C.~o 
"NH 2.. 
+ L.i- 01-.1 
Precipitation of' tet:racyclin~ ... 7·boronic acid occurred, 
presumably due . to dif'fe:rel;),ces . in the sol~bil:tty of' 7• 
ohlorotetJ?acycline and tetracycli.n~-7·bpronic .· ac.id in 
tetrahydrofur-e.rh 7'7chlorotetracy~line has a. maximum 
solubility of 14.•9 mg/ral in tetrahydrofuran at 2,5°C, 
9 
whereas tetraoycline•7·boron:i.c acid has a maxi:mt.un solubil:J. ty 
of' only 7.6 mg/ml in tetrahydrof'ura.n at 25°0 and 6.9 mg/ml 
----
tn-boiTing tetre.hydrofuran (66°0). 
The mixtur'e of' solids containing boric ac::J.d, 
lithium borate and tetra.cycline.;,.7•boronic a.cid was 
filtered by suction at 66°C~ The subt:rliances on the filter 
were washed with cold absolute ethanolto remove boric 
acid and lithium borate. The remaining crude tetra• 
oycline•7•boronic acid was dried !!! v.aouo (yield 48.4% 
theoretical). 
The crude tetracyclina-7•boronio acid was a yellow 
material which analyzed .. a maxitnum of 1•84.% boron. · 
Oal~ulated :f'oJ? tetra.cycline•7•boron:to acid is 2.21.1.%• 
The method of boron analysis is discussed in a later 
section of this chapter• 
Alkali fusion of the tetracyclines has been shown 
by :Pasternao.k (16) to yield both derivatives of salicyolio 
acid and m•hydroxybenzoic acid from the left hand ring 
of the tetracycline molecule. Thus by anology with 
Pasternack) a result) the degradation of tetracycline•? ... 
boronic a.o id by e.lkali fusion rnay be expected to proceed 
' 
as follows: 
Ol--i... 
oi-l 
(_ -;::0 
'oH 
+ Degradation Products 
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st~rio hindrance should prevent the formation of 
4-hydroxy•l•boro•ben~oio acid. 
Following closely the method used by Pasternack 
to isolate salioyclic ·acid, an attempt was made to isolate 
$•borosalicylic acid. 12•5 grams or tetracycline-?• 
boJ;>onic acid were added portionwise over one half hour 
to a melt of sixty .grams of potassium hydroxide and thi:roty 
gPantS of sodiurrl hydroxide at 200° to 210°0. After one 
hour of futhur heating the melt was cooled, dissolved in 
two hundred milliliters of water.· acidified with. 50% 
h~drochloric acid and extracted with three seventy five 
:milliliter portions of ethyl acetate. The ethyl acetate 
------
extract was evaporated to dryness and the black tarry 
product sublimed at 200°0 (l:mm.) to yield 1.08 grams of 
brownish oily crystals. 
11 
Treatment of an aqueous solution of the sublimed 
material with activated charcoal did not remove all the 
colored impurities pl:'lesant in a single treatment. A 
second a.ctiva.ted oh.a.rcoal treatment and .t"ractional 
crystallization of the material from water yielded 
approximately twenty milligrams of white crystals with 
a melting point of 158° to 159°0 and .0624 grams of a 
brownish crystalline material with a melting point of 
169° to 180°c. The crystalline material which showed a 
melting point of 158<•, to 159°0, when mixed with an 
authentic sample of salicylic acid)did not depress the 
melting point$ The brownish crystalline material could 
not be purified. further d'q.e to the small amount present. 
The brownish crystalline material has been studied 
and the following evidence indicates 'lihe presence of a 
carbon-boron bond~ Under. the conditions of the sublimation 
of the fusion products, as outlined by Pasternack (16), 
boric acid will not sublime. Alkali fusion and acidifi• 
'cation of ·che tetl?acyolina-?•boronic acid would likely 
produce boric ao:td unless a oarbon•boron bond were present. 
The sublimed material when subjected to flame photometrio 
analysis shows a strong boron emission band bett'lfeen .548..1'M ..t..L.-
and 566~, 
I 
! 
I 
-
~ 
" 
12 
Methyl borate has been extensively used in the 
detection and determination of boron as, bovic acid. Many 
methods have. beeh proposed in which the boric acid is 
separated from acoorapa:n:y:tng substru1ces by converting to . 
the volatile methyl borate and distilling {17•23). The 
distille:lie can be subjected to flame photometric methods 
of analysis (24). 
The samples of tetraoycline•7-bor.onic acid were 
analysed for boron content• by the following procedure. 
The samples 'tve:re digested with four milliliters of boron 
. free concentrated sulfuric acid in a two hundred and fifty 
milliliter flask mod:i.fied for either r•eflux or distillation. 
Tenmilliliters of boron free methanol was added Md the 
mixtm-ae refluxed for fifteen minutes, pivoted to the 
distillation position and the solution distilled to a 
tempevatm~e of· 706 0. Ten rnillili ters of :methanol was 
·added to the distillation flask and the solution again 
distilled to 70°0• A final ten milliliters of methanol 
was added to the distillation flask and the solution 
distilled to a volume of twenty five milliliters- The 
distillate obtained was subjected to .fltame photometric 
a.nalysis and compared to a stand~d which was prepared by 
the same method. The standard was prepared by plotting 
the log of the optical density versus the concentration 
of boron in micrograms per millilitero A flame attachment 
with a Beckman model B spectophotometer was used in the 
13 
studies. 
Presence of sodium in the dist:i.llat~ of methyl 
borate results in higher optic~l density readings of the 
boron· emission sp~et:rum. (24.). I.t was found that a 
o?noentrat:ton of one microgram; or less., of sodium per 
milliliter did not cause error in the boron analysis. 
f----~~~-----"B"-'-a----'f_f_::l_c_e_plates :built into the distillation flask PRJ~ve_nj;~d..~~~__:___ 
spray 1 . oonta:i.ning sodium, being carried over into the 
distillate. A diagram of the ~pparatua used appears in 
figure 2,. 
.FIGURE l 
DIAGRAM OF THE APPARATtTS USED :POR Tim PREPARATION OF 
7•LITHIUM TETRACYCLINE 
A 
F 
A) D~ying tube 
ll) Inlet fo:r the 7•ohlorotet:racyeline•tetrahydrof'uren 
solution 
0) Stopcock 
D) Metallic lithium reaction vessel 
E) Sintered glass filte:r> 
F) Collection flask 
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F'IGURE 2 
. :biAGRA~l OF THE APPARATUS USED FOR BORON DETERMINATION 
A) Reaction and distillation flask 
·B) Baffle plates 
0 ) Inlet f.~r acid and :m,~thanol , 
D) Thermometer 
E) Water cooled Qondenser 
F) Ice cooled trap 
G) Volumetric flask 
H) Pivot for setting the apparatus in either reflux or 
distillation position 
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OHAPTF.m III 
DISCUSSION 
The presence of chloride ion in the insoluble 
residue from the lith:tu.:m meta1""7-ohlorotetracycline 
reaction has shown the successful removal of the chlorine. 
Replacement of the li·bhium by boric aoid is not described 
;tn-th~e-J:tt-erature;. lloweve~:~rt-was-incfioatea-by-aho:ron 
emission band present in flame.photomat:ric analysis of the 
alkali fusion products of tetracyeline..-7-boron:to ao:td. 
5-borosalioyolio acid" which may be one of the 
degradation products of alkali fusion of tetracycline•7-
boronio acid is not described in the literature; however, 
the synthesis of the compound is being attempted at 
College of the Pacific. 
Futher studies are suggested in the areas of better 
methods of synthesis of tetraoycline·7~boronio acid, 
preventing gum•like mate:r:tal f'orming and studies of the 
t:Wyl-.lithiu.m-borie acid reaction~ It is evident that the 
. above problems which exist must be completed before an 
absolute p.repa.vation of tet:raoycline...,7•bo.ronio acid n1ay 
be claimed. 
~~------~-~ 
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